Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Yoshitsugu Aoki

National Center of Neurology and Psychiatry

Research Interests

Explore related searches

Articles (20)

Collaborators (8)

Tsukasa Tominari

Section Chief

National Center of Neurology and Psychiatry

Gavin Y. Oudit

University of Alberta

Yoshifumi Itoh

University of Oxford

UNITED KINGDOM

Takashi Yamada

Associate Professor

Sapporo Medical University

Francesco Muntoni

University College London

UNITED KINGDOM

Masaki Inada

Takemura Fusako

Waseda University

Toshifumi Yokota

University of Alberta

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Yoshitsugu Aoki

Research Interests

Explore related searches

Articles (20)

Collaborators (8)

Tsukasa Tominari

Gavin Y. Oudit

Yoshifumi Itoh

Takashi Yamada

Francesco Muntoni

Masaki Inada

Takemura Fusako

Toshifumi Yokota

Make your next move.

Yoshitsugu Aoki

Research Interests

Explore related searches

Articles (20)

Making brain health routine in Duchenne muscular dystrophy: What the BIND screener adds—and what it is not designed to do

DMD-Null mice exhibit severe muscle weakness, impaired regeneration, and deficient satellite cell function

RNA Therapeutics for Duchenne Muscular Dystrophy: Exon Skipping, RNA Editing, and Translational Insights from Genome-Edited Microminipig Models

Fatigue Resistance and Mitochondrial Adaptations to Isometric Interval Training in Dystrophin‐Deficient Muscle: Role of Contractile Load

Polyplex Nanomicelle‐Mediated Pgc‐1α4 mRNA Delivery Via Hydrodynamic Limb Vein Injection Enhances Damage Resistance in Duchenne Muscular Dystrophy Mice

Duchenne muscular dystrophy: recent insights in brain related comorbidities

Glutamine Promotes Myogenesis in Myoblasts Through Glutaminolysis-Mediated Histone H3 Acetylation That Enhances Myogenin Transcription

Protocol for using MYOD1-transduced human urine-derived cells as a predictive platform for exon skipping therapy in Duchenne muscular dystrophy

Electrophysiological Evaluation in mdx52 Mouse Brain After Antisense-Mediated Exon 51 or 53 Skipping

Allele-specific CRISPR-Cas9 editing inactivates a single-nucleotide variant associated with collagen VI muscular dystrophy

Severe cardiac and skeletal manifestations in DMD-edited microminipigs: an advanced surrogate for Duchenne muscular dystrophy

High‐intensity interval training in the form of isometric contraction improves fatigue resistance in dystrophin‐deficient muscle

Ensemble-Learning and Feature Selection Techniques for Enhanced Antisense Oligonucleotide Efficacy Prediction in Exon Skipping

Antioxidants restore store‐operated Ca2+ entry in patient‐iPSC‐derived myotubes with tubular aggregate myopathy‐associated Ile484ArgfsX21 STIM1 mutation via upregulation of binding immunoglobulin protein

Establishment of a Triple Quadrupole HPLC-MS Quantitation Method for Dystrophin Protein in Mouse and Human Skeletal Muscle

Resolution of fibrosis in mdx dystrophic mouse after oral consumption of N-163 strain of Aureobasidium pullulans produced β-glucan.

Exon 44 skipping in Duchenne muscular dystrophy: NS-089/NCNP-02, a dual-targeting antisense oligonucleotide.

Systemic administration of the antisense oligonucleotide NS‐089/NCNP‐02 for skipping of exon 44 in patients with Duchenne muscular dystrophy: Study protocol for a phase I/II clinical trial

Mr. Takashi Onaka Memorial Oration: I. Updates on solutions to DMD.

Quantitative Evaluation of Exon Skipping in Urine-Derived Cells for Duchenne Muscular Dystrophy.

Collaborators (8)

Tsukasa Tominari

Gavin Y. Oudit

Yoshifumi Itoh

Takashi Yamada

Francesco Muntoni

Masaki Inada

Takemura Fusako

Toshifumi Yokota

Make your next move.